Research Article
Spatial Frailty Survival Model for Multidrug-Resistant Tuberculosis Mortality in Amhara Region, Ethiopia
Table 2
Summary results of MDR–TB by clinical characteristics.
| | Covariates | Category | Death (%) | Censored (%) | Total (%) |
| | Any clinical complication | No complication | 35(20.35) | 137(79.65) | 172 | | Pneumonia | 7(87.5) | 1(12.5) | 8 | | Pneumothorax | 6(85.71) | 1(14.29) | 7 | | Hemoptysis | 7(63.64) | 4(36.36) | 11 | | Cor pulmonal | 4(100) | 0(0) | 4 | | Other | 2(40) | 3(60) | 5 | | HIV Co-infection | Positive | 21(61.76) | 13(38.24) | 34 | | Negative | 40(23.12) | 133(76.88) | 173 | | Acid-fast bacilli Smear (AFB) | positive | 43(28.28) | 109(71.71) | 152 | | Negative | 12(30) | 28(70) | 40 | | Antibiotic Susceptibility | INH | 6(72.86) | 8(57.14) | 14 | | RMP | 24(30.38) | 55(69.62) | 79 | | MDR | 26(30.95) | 58(69.05) | 84 | | INH+RMP | 5(16.67) | 25(83.33) | 30 | | Presence of any chronic disease | No chronic disease | 42(24.14) | 132(75.86) | 174 | | Diabetes Mellitus | 8(50) | 8(50) | 16 | | Myocardial infarction | 4(100) | 0(0) | 4 | | Asthma | 4(66.66) | 2(33.33) | 6 | | other | 1(33.33) | 2(66.67) | 3 | | Radiological findings | unilateral cavity | 9(26.47) | 25(73.53) | 34 | | unilateral infiltration | 3(33.33) | 6(66.67) | 9 | | Bilateral cavity | 4(18.18) | 18(81.82) | 22 | | Bilateral inflation | 7(38.89) | 11(61.12) | 18 | | Non cavity | 14(27.45) | 37(72.55) | 51 | | Effusion | 12(37.5) | 20(62.5) | 32 | | Smear positivity | Positive | 46(31.94) | 98(68.06) | 144 | | Negative | 14(26.42) | 39(73.58) | 53 | | Clinical Presentation | Pulmonary | 51(30) | 119(70) | 170 | | Extra pulmonary | 8(28.57) | 20(71.43) | 28 |
|
|
INH: isoniazid; RMP: rifampicin; MDR: multidrug-resistant.
|
